4 studies found for:    thyroid AND surgery AND Northwestern
Show Display Options
Rank Status Study
1 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
2 Recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Conditions: Metastatic Gastrointestinal Carcinoid Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Neuroendocrine Carcinoma of the Skin;   Regional Gastrointestinal Carcinoid Tumor;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: pazopanib hydrochloride;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
3 Completed A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer [F];   Advanced Breast Cancer;   Metastatic Castration Resistant Prostate Cancer;   Metastatic Renal Cell Cancer;   Non-Small Cell Lung Cancer;   Thyroid Cancer;   Advanced/Metastatic Non-Small Cell Lung Cancer;   Advanced Gastric Cancer;   Gastrointestinal Stromal Tumor;   Hepatocellular Carcinoma;   Pancreatic Islet Cell Carcinoma;   Pancreatic Neuroendocrine Tumor
Intervention: Drug: sunitinib
4 Completed The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Teplizumab;   Other: Placebo

Indicates status has not been verified in more than two years